Successful thrombolysis following enoxaparin therapy in two pediatric patients with congenital heart disease presenting with intracardiac and cerebral thrombosis View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-12

AUTHORS

Gesa Wiegand, Vanya Icheva, Martin Schöning, Michael Hofbeck

ABSTRACT

Enoxaparin displays fibrinolytic activity through stimulation of endothelial release of tissue plasminogen activator. Moreover, enoxaparin increases the release of tissue factor pathway inhibitor, which inhibits coagulation activity. However, there are only few reports regarding the use of enoxaparin for the treatment of children with thrombosis complicating congenital heart disease. We report the clinical findings from two patients, one child with an A. cerebri media infarction and another with a left ventricular thrombus. In both cases successful thrombolysis was obtained by intravenous administration of enoxaparin. The first patient was a 12-year-old girl with an atrioventricular septal defect, who underwent biventricular repair at the age of 8 months. She presented with right-sided middle cerebral artery infarction. Thrombolysis was contraindicated, because she was beyond the therapeutic window recommended by accepted guidelines. Enoxaparin 2.5 mg/kg/d was administered as a continuous intravenous infusion (CII). The MRI 10 days later revealed a reopened middle cerebral artery and she experienced complete remission of the neurological signs. The second patient was a 16-year-old boy who had tetralogy of Fallot corrected in late infancy. He presented with severe heart failure and a mural thrombus in the left ventricular apex. Enoxaparin was administered and resulted in complete disappearance of the thrombus within a week. According to our experience, CII of enoxaparin was safe and well tolerated without secondary bleeding and resulted in complete dissolution of the thrombi without secondary embolization. Therefore, CII of enoxaparin may be a possible alternative for the treatment of thrombotic complications in children with contraindications against conventional thrombolytic therapy. More... »

PAGES

19

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1477-9560-12-19

DOI

http://dx.doi.org/10.1186/1477-9560-12-19

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1028543535

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25278813


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Pediatric Cardiology, University Children\u2019s Hospital, Hoppe-Seyler-Strasse 1, 72076, Tuebingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wiegand", 
        "givenName": "Gesa", 
        "id": "sg:person.01016064141.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016064141.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Pediatric Cardiology, University Children\u2019s Hospital, Hoppe-Seyler-Strasse 1, 72076, Tuebingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Icheva", 
        "givenName": "Vanya", 
        "id": "sg:person.01231423256.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231423256.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universit\u00e4tsklinikum T\u00fcbingen", 
          "id": "https://www.grid.ac/institutes/grid.411544.1", 
          "name": [
            "Department of Pediatric Neurology, University Children\u2019s Hospital, Tuebingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sch\u00f6ning", 
        "givenName": "Martin", 
        "id": "sg:person.01005076763.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005076763.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Pediatric Cardiology, University Children\u2019s Hospital, Hoppe-Seyler-Strasse 1, 72076, Tuebingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hofbeck", 
        "givenName": "Michael", 
        "id": "sg:person.0752260403.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752260403.55"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0049-3848(03)00059-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004808883"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.ccm.0000059725.60509.a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006225509"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.ccm.0000059725.60509.a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006225509"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00254798", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006748006", 
          "https://doi.org/10.1007/bf00254798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00254798", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006748006", 
          "https://doi.org/10.1007/bf00254798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/str.0b013e318284056a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020032012"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/str.0b013e318284056a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020032012"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/pcc.0b013e31818d1920", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024902043"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/pcc.0b013e31818d1920", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024902043"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1538-7836.2010.03964.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026194188"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1538-7836.2010.03964.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026194188"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000217270", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028426083"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.2006.02650.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034129583"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.289.3.331", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035769928"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.160.2.229", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040841475"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2710.2005.00634.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043460779"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2710.2005.00634.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043460779"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/fn.88.5.f365", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043493045"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1155/2011/981497", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043896651"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.2005.02452.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053247965"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.2005.02452.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053247965"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.11-2308", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067172033"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077191637", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077332519", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-12", 
    "datePublishedReg": "2014-12-01", 
    "description": "Enoxaparin displays fibrinolytic activity through stimulation of endothelial release of tissue plasminogen activator. Moreover, enoxaparin increases the release of tissue factor pathway inhibitor, which inhibits coagulation activity. However, there are only few reports regarding the use of enoxaparin for the treatment of children with thrombosis complicating congenital heart disease. We report the clinical findings from two patients, one child with an A. cerebri media infarction and another with a left ventricular thrombus. In both cases successful thrombolysis was obtained by intravenous administration of enoxaparin. The first patient was a 12-year-old girl with an atrioventricular septal defect, who underwent biventricular repair at the age of 8\u00a0months. She presented with right-sided middle cerebral artery infarction. Thrombolysis was contraindicated, because she was beyond the therapeutic window recommended by accepted guidelines. Enoxaparin 2.5\u00a0mg/kg/d was administered as a continuous intravenous infusion (CII). The MRI 10\u00a0days later revealed a reopened middle cerebral artery and she experienced complete remission of the neurological signs. The second patient was a 16-year-old boy who had tetralogy of Fallot corrected in late infancy. He presented with severe heart failure and a mural thrombus in the left ventricular apex. Enoxaparin was administered and resulted in complete disappearance of the thrombus within a week. According to our experience, CII of enoxaparin was safe and well tolerated without secondary bleeding and resulted in complete dissolution of the thrombi without secondary embolization. Therefore, CII of enoxaparin may be a possible alternative for the treatment of thrombotic complications in children with contraindications against conventional thrombolytic therapy. ", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1477-9560-12-19", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1032055", 
        "issn": [
          "1477-9560"
        ], 
        "name": "Thrombosis Journal", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "name": "Successful thrombolysis following enoxaparin therapy in two pediatric patients with congenital heart disease presenting with intracardiac and cerebral thrombosis", 
    "pagination": "19", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "87f91f211eff8e96e809c4e3785b243f8fa577fb1ca9bef5c00a9c5b10706625"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25278813"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101170542"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1477-9560-12-19"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1028543535"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1477-9560-12-19", 
      "https://app.dimensions.ai/details/publication/pub.1028543535"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:59", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000347_0000000347/records_89814_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1477-9560-12-19"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1477-9560-12-19'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1477-9560-12-19'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1477-9560-12-19'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1477-9560-12-19'


 

This table displays all metadata directly associated to this object as RDF triples.

145 TRIPLES      21 PREDICATES      46 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1477-9560-12-19 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author Nbed039a43781492c9af36beba8bfe5cd
4 schema:citation sg:pub.10.1007/bf00254798
5 https://app.dimensions.ai/details/publication/pub.1077191637
6 https://app.dimensions.ai/details/publication/pub.1077332519
7 https://doi.org/10.1001/archinte.160.2.229
8 https://doi.org/10.1001/jama.289.3.331
9 https://doi.org/10.1016/s0049-3848(03)00059-8
10 https://doi.org/10.1097/01.ccm.0000059725.60509.a0
11 https://doi.org/10.1097/pcc.0b013e31818d1920
12 https://doi.org/10.1111/j.1365-2125.2005.02452.x
13 https://doi.org/10.1111/j.1365-2125.2006.02650.x
14 https://doi.org/10.1111/j.1365-2710.2005.00634.x
15 https://doi.org/10.1111/j.1538-7836.2010.03964.x
16 https://doi.org/10.1136/fn.88.5.f365
17 https://doi.org/10.1155/2011/981497
18 https://doi.org/10.1159/000217270
19 https://doi.org/10.1161/str.0b013e318284056a
20 https://doi.org/10.1378/chest.11-2308
21 schema:datePublished 2014-12
22 schema:datePublishedReg 2014-12-01
23 schema:description Enoxaparin displays fibrinolytic activity through stimulation of endothelial release of tissue plasminogen activator. Moreover, enoxaparin increases the release of tissue factor pathway inhibitor, which inhibits coagulation activity. However, there are only few reports regarding the use of enoxaparin for the treatment of children with thrombosis complicating congenital heart disease. We report the clinical findings from two patients, one child with an A. cerebri media infarction and another with a left ventricular thrombus. In both cases successful thrombolysis was obtained by intravenous administration of enoxaparin. The first patient was a 12-year-old girl with an atrioventricular septal defect, who underwent biventricular repair at the age of 8 months. She presented with right-sided middle cerebral artery infarction. Thrombolysis was contraindicated, because she was beyond the therapeutic window recommended by accepted guidelines. Enoxaparin 2.5 mg/kg/d was administered as a continuous intravenous infusion (CII). The MRI 10 days later revealed a reopened middle cerebral artery and she experienced complete remission of the neurological signs. The second patient was a 16-year-old boy who had tetralogy of Fallot corrected in late infancy. He presented with severe heart failure and a mural thrombus in the left ventricular apex. Enoxaparin was administered and resulted in complete disappearance of the thrombus within a week. According to our experience, CII of enoxaparin was safe and well tolerated without secondary bleeding and resulted in complete dissolution of the thrombi without secondary embolization. Therefore, CII of enoxaparin may be a possible alternative for the treatment of thrombotic complications in children with contraindications against conventional thrombolytic therapy.
24 schema:genre research_article
25 schema:inLanguage en
26 schema:isAccessibleForFree true
27 schema:isPartOf N23b8062e1bc248d79a7a5b96a52be995
28 Ne00117e4fbd94093abb44ad8d47effd6
29 sg:journal.1032055
30 schema:name Successful thrombolysis following enoxaparin therapy in two pediatric patients with congenital heart disease presenting with intracardiac and cerebral thrombosis
31 schema:pagination 19
32 schema:productId N0e1c7e09846a4b2597c302cd2bf1cda1
33 N4f031282062c47caa0183a156205b817
34 N7c9a17822c9d4d4c9d9a690f23625d26
35 N8c2e8d8d7bcf49c1a3f3279a4940e5d4
36 Nbfe7ea03e14b4ddc9530ec6b76852679
37 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028543535
38 https://doi.org/10.1186/1477-9560-12-19
39 schema:sdDatePublished 2019-04-11T09:59
40 schema:sdLicense https://scigraph.springernature.com/explorer/license/
41 schema:sdPublisher N826a0d08b8d44b4fa219bb1613277c5f
42 schema:url http://link.springer.com/10.1186%2F1477-9560-12-19
43 sgo:license sg:explorer/license/
44 sgo:sdDataset articles
45 rdf:type schema:ScholarlyArticle
46 N0e1c7e09846a4b2597c302cd2bf1cda1 schema:name nlm_unique_id
47 schema:value 101170542
48 rdf:type schema:PropertyValue
49 N23b8062e1bc248d79a7a5b96a52be995 schema:volumeNumber 12
50 rdf:type schema:PublicationVolume
51 N26dfdb298bce4fa8b95c8c48c4098b91 rdf:first sg:person.0752260403.55
52 rdf:rest rdf:nil
53 N4f031282062c47caa0183a156205b817 schema:name pubmed_id
54 schema:value 25278813
55 rdf:type schema:PropertyValue
56 N59ebc4f6d49842d399273906b532f041 rdf:first sg:person.01005076763.41
57 rdf:rest N26dfdb298bce4fa8b95c8c48c4098b91
58 N6338fcaf16484b2dada0983ae1e1a7cb schema:name Department of Pediatric Cardiology, University Children’s Hospital, Hoppe-Seyler-Strasse 1, 72076, Tuebingen, Germany
59 rdf:type schema:Organization
60 N74082e7093f14865b6798a124cfda98b rdf:first sg:person.01231423256.03
61 rdf:rest N59ebc4f6d49842d399273906b532f041
62 N7c9a17822c9d4d4c9d9a690f23625d26 schema:name doi
63 schema:value 10.1186/1477-9560-12-19
64 rdf:type schema:PropertyValue
65 N826a0d08b8d44b4fa219bb1613277c5f schema:name Springer Nature - SN SciGraph project
66 rdf:type schema:Organization
67 N8c2e8d8d7bcf49c1a3f3279a4940e5d4 schema:name readcube_id
68 schema:value 87f91f211eff8e96e809c4e3785b243f8fa577fb1ca9bef5c00a9c5b10706625
69 rdf:type schema:PropertyValue
70 N99637b66d2e8467f86350ffb7896a402 schema:name Department of Pediatric Cardiology, University Children’s Hospital, Hoppe-Seyler-Strasse 1, 72076, Tuebingen, Germany
71 rdf:type schema:Organization
72 Nbed039a43781492c9af36beba8bfe5cd rdf:first sg:person.01016064141.48
73 rdf:rest N74082e7093f14865b6798a124cfda98b
74 Nbfe7ea03e14b4ddc9530ec6b76852679 schema:name dimensions_id
75 schema:value pub.1028543535
76 rdf:type schema:PropertyValue
77 Ne00117e4fbd94093abb44ad8d47effd6 schema:issueNumber 1
78 rdf:type schema:PublicationIssue
79 Nfae7cd90d4c34a83a6a4d169a95e6c43 schema:name Department of Pediatric Cardiology, University Children’s Hospital, Hoppe-Seyler-Strasse 1, 72076, Tuebingen, Germany
80 rdf:type schema:Organization
81 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
82 schema:name Medical and Health Sciences
83 rdf:type schema:DefinedTerm
84 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
85 schema:name Cardiorespiratory Medicine and Haematology
86 rdf:type schema:DefinedTerm
87 sg:journal.1032055 schema:issn 1477-9560
88 schema:name Thrombosis Journal
89 rdf:type schema:Periodical
90 sg:person.01005076763.41 schema:affiliation https://www.grid.ac/institutes/grid.411544.1
91 schema:familyName Schöning
92 schema:givenName Martin
93 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005076763.41
94 rdf:type schema:Person
95 sg:person.01016064141.48 schema:affiliation Nfae7cd90d4c34a83a6a4d169a95e6c43
96 schema:familyName Wiegand
97 schema:givenName Gesa
98 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016064141.48
99 rdf:type schema:Person
100 sg:person.01231423256.03 schema:affiliation N99637b66d2e8467f86350ffb7896a402
101 schema:familyName Icheva
102 schema:givenName Vanya
103 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231423256.03
104 rdf:type schema:Person
105 sg:person.0752260403.55 schema:affiliation N6338fcaf16484b2dada0983ae1e1a7cb
106 schema:familyName Hofbeck
107 schema:givenName Michael
108 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752260403.55
109 rdf:type schema:Person
110 sg:pub.10.1007/bf00254798 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006748006
111 https://doi.org/10.1007/bf00254798
112 rdf:type schema:CreativeWork
113 https://app.dimensions.ai/details/publication/pub.1077191637 schema:CreativeWork
114 https://app.dimensions.ai/details/publication/pub.1077332519 schema:CreativeWork
115 https://doi.org/10.1001/archinte.160.2.229 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040841475
116 rdf:type schema:CreativeWork
117 https://doi.org/10.1001/jama.289.3.331 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035769928
118 rdf:type schema:CreativeWork
119 https://doi.org/10.1016/s0049-3848(03)00059-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004808883
120 rdf:type schema:CreativeWork
121 https://doi.org/10.1097/01.ccm.0000059725.60509.a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006225509
122 rdf:type schema:CreativeWork
123 https://doi.org/10.1097/pcc.0b013e31818d1920 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024902043
124 rdf:type schema:CreativeWork
125 https://doi.org/10.1111/j.1365-2125.2005.02452.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1053247965
126 rdf:type schema:CreativeWork
127 https://doi.org/10.1111/j.1365-2125.2006.02650.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1034129583
128 rdf:type schema:CreativeWork
129 https://doi.org/10.1111/j.1365-2710.2005.00634.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1043460779
130 rdf:type schema:CreativeWork
131 https://doi.org/10.1111/j.1538-7836.2010.03964.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1026194188
132 rdf:type schema:CreativeWork
133 https://doi.org/10.1136/fn.88.5.f365 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043493045
134 rdf:type schema:CreativeWork
135 https://doi.org/10.1155/2011/981497 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043896651
136 rdf:type schema:CreativeWork
137 https://doi.org/10.1159/000217270 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028426083
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1161/str.0b013e318284056a schema:sameAs https://app.dimensions.ai/details/publication/pub.1020032012
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1378/chest.11-2308 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067172033
142 rdf:type schema:CreativeWork
143 https://www.grid.ac/institutes/grid.411544.1 schema:alternateName Universitätsklinikum Tübingen
144 schema:name Department of Pediatric Neurology, University Children’s Hospital, Tuebingen, Germany
145 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...